Calhoun, William J.
Chupp, Geoffrey L.
Funding for this research was provided by:
Boehringer Ingelheim Pharmaceuticals, Inc.
Article History
Received: 4 March 2021
Accepted: 12 April 2022
First Online: 21 May 2022
Declarations
:
: Not applicable.
: Not applicable.
: GLC reports personal fees and other fees (consultant, speakers bureau, and clinical trial site) from GlaxoSmithKline, Boehringer Ingelheim Pharmaceuticals, Genentech, AstraZeneca, Sanofi Genzyme, and Regeneron outside the submitted work. WJC report personal fees from Genentech and grants from AstraZeneca and Sanofi, outside the submitted work.